Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,715.1
7.9 (0.29%)

 

  • STI Straits Times Index
    2,715.1
    7.9 (0.29%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,561.8
    -
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,366.3
    -
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,919.3
    -
    Index delayed 15 minutes
  • N225 Nikkei 225
    22,613.3
    -82.5 (-0.36%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,916.7
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 8.9M
  • Value: 17.3M
  • Rise: -
  • Fall: -
  • Unch: 809

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
MDR0.001-
ThaiBev0.705-
Singtel2.650+0.070
SIA4.400+0.020
Mapletree Com Tr2.100+0.020
SPH1.330-0.040
ESR-REIT0.410-
3Cnergy0.024-
Y Ventures0.088+0.002
Mapletree Ind Tr2.740+0.090

World Indices

World Indices
Name Last Change
Nasdaq 9,615.8 -67.1
HSI 24,366.3
HSCEI 9,967.9
Jakarta 4,916.7
Nikkei 225 22,612.5 -83.2
SSE Comp 2,919.3
Shanghai A 3,060.0
Shanghai B 205.7
KOSPI 2,149.4 -1.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

MERRIMACK PHARMACEUTICALS INC MERRIMACK PHARMACEUTICALS
Updated on 03 Jun 2020 (End of trading day)
Last (USD): 3.500 Change: -0.020 High: 3.610 Remarks: -
Change (%): -0.57 Low: 3.480
Open 3.540 Yesterday's Close 3.52
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 28,372 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.58944 Trailing EPS (USD) e -0.78923 NAV (USD) b 1.3486
PE a - Trailing PE f - Price / NAV b 2.5953
Dividend (USD) d 0.500731 Cash In Hand (USD) g 1.3471 Issued & Paid-up Shares c 13,380,200
Dividend Yield (%) d 14.307 Price / Cash In Hand g 2.598 Treasury Shares h -
Beta - 75 Daysi 0.522 R-Squared - 75 Days(%)i 13.57 Market Cap (M) 46.831
Beta - 500 Daysi 0.282 R-Squared - 500 Days (%)i 1.35 Enterprise Value (M) 28.806
Piotroski F Score 2 Exchange Code MACK Par Value ( $ ) n.a.
52 Weeks Volatility (%) 84.30 Free Float (%) 96.7
Sector & Industry Health Technology - Biotechnology
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 24 Apr 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference MERRIMACK PHARMACEUTICALS INC NASDAQ 46.831 - - 2.5953 14.307
Industry Biotechnology NASDAQ 2,783.510 349.979 5174.146 6.7671 0.693
Local Peer AMGEN INC NASDAQ 130,002.587 16.578 16.938 13.7061 2.639
Local Peer GILEAD SCIENCES INC NASDAQ 93,297.600 17.322 18.802 4.2279 3.420
Local Peer VERTEX PHARMACEUTICAL NASDAQ 71,822.322 61.031 47.535 11.1152 -
Local Peer REGENERON PHARMACEUTICALS INC NASDAQ 67,994.776 32.137 29.831 5.6041 -
Local Peer ILLUMINA INC NASDAQ 52,673.040 52.568 55.916 11.3642 -
Local Peer BIOGEN INC NASDAQ 49,380.386 8.386 8.400 3.9357 -
Local Peer SEATTLE GENETICS INC NASDAQ 26,839.465 - - 15.2011 -
Local Peer ALEXION PHARMACEUTICAL INC NASDAQ 25,123.488 10.449 10.583 2.1386 -
Local Peer MODERNA INC NASDAQ 22,232.605 - - 13.5492 -
Local Peer INCYTE CORPORATION NASDAQ 21,482.974 48.070 - 11.0867 -
Local Peer BIOMARIN PHARMACEUTICAL NASDAQ 20,110.883 - 176.402 6.2071 -
Local Peer ALNYLAM PHARMACEUTICALS INC NASDAQ 15,519.132 - - 11.4980 -
Other Local Peers EXACT SCIENCES CORP (NASDAQ), BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS (NASDAQ), GALAPAGOS NV SPON ADR REPR 1 ORD SHS (NASDAQ), BIONTECH SE SPON ADS EACH REP 1 ORD SHS (NASDAQ), SAREPTA THERAPEUTICS INC (NASDAQ), NEUROCRINE BIOSCIENCES INC (NASDAQ), BIO-TECHNE CORP (NASDAQ), 10X GENOMICS INC (NASDAQ), IONIS PHARMACEUTICALS INC (NASDAQ), ACADIA PHARMACEUTICALS INC (NASDAQ), IMMUNOMEDICS INC (NASDAQ), EXELIXIS INC (NASDAQ), ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS (NASDAQ), ALLOGENE THERAPEUTICS INC (NASDAQ), ZAI LAB LIMITED ADS EACH REP 1 ORD SHS (NASDAQ), ACCELERON PHARMA (NASDAQ), IOVANCE BIOTHERAPEUTICS INC (NASDAQ), ULTRAGENYX PHARMACEUTICAL INC (NASDAQ), MIRATI THERAPEUTICS INC (NASDAQ), MORPHOSYS SPON ADS EACH REP 0.25 ORD SHS (NASDAQ), CHINA BIOLOGIC PRODUCTS HLDGS INC (NASDAQ), BLUEBIRD BIO INC (NASDAQ), GLOBAL BLOOD THERAPEUTICS INC (NASDAQ), BLUEPRINT MEDICINES CORP (NASDAQ), CRISPR THERAPEUTICS AG (NASDAQ), VIR BIOTECHNOLOGY INC (NASDAQ), ARENA PHARMACEUTICALS INC (NASDAQ), CHEMOCENTRYX INC (NASDAQ), AGIOS PHARMACEUTICALS INC (NASDAQ), MOMENTA PHARMACEUTICALS INC (NASDAQ), AMICUS THERAPEUTICS INC (NASDAQ), ARROWHEAD PHARMACEUTICALS INC (NASDAQ), HALOZYME THERAPEUTICS INC (NASDAQ), PTC THERAPEUTICS INC (NASDAQ), DECIPHERA PHARMACEUTICALS INC (NASDAQ), DENALI THERAPEUTICS INC (NASDAQ), VIELA BIO INC (NASDAQ), FIBROGEN INC (NASDAQ), KODIAK SCIENCES INC (NASDAQ), UNIQURE N.V. (NASDAQ), ALKERMES PLC (NASDAQ), INSMED INC (NASDAQ), NOVAVAX INC (NASDAQ), ALECTOR INC (NASDAQ), FATE THERAPEUTICS (NASDAQ), BENITEC BIOPHARMA INC (NASDAQ), TG THERAPEUTICS INC (NASDAQ), EIDOS THERAPEUTICS INC (NASDAQ), LIGAND PHARMACEUTICAL INC (NASDAQ), ZENTALIS PHARMACEUTICALS INC (NASDAQ), ADAPTIMMUNE THERAPEUTICS PLC ADS EACH REPR 6 SHS (SPONS) (NASDAQ), EPIZYME INC (NASDAQ), XENCOR INC (NASDAQ), HERON THERAPEUTICS INC (NASDAQ), AURINIA PHARMACEUTICALS INC (NASDAQ), AKEBIA THERAPEUTICS INC (NASDAQ), ADVERUM BIOTECHNOLOGIES INC (NASDAQ), SANGAMO THERAPEUTICS INC (NASDAQ), MESOBLAST LTD SPON ADR EACH REP 5 SHS (NASDAQ), TWIST BIOSCIENCE CORPORATION (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), EDITAS MEDICINE INC (NASDAQ), BEAM THERAPEUTICS INC (NASDAQ), BLACK DIAMOND THERAPEUTICS INC (NASDAQ), LUMINEX CORP(DEL) (NASDAQ), REGENXBIO INC (NASDAQ), NGM BIOPHARMACEUTICALS INC (NASDAQ), INTRA-CELLUAR THERAPIES INC (NASDAQ), COMPUGEN (NASDAQ), MERSANA THERAPEUTICS INC (NASDAQ), COHERUS BIOSCIENCES INC (NASDAQ), ARVINAS INC (NASDAQ), VERACYTE INC (NASDAQ), KARYOPHARM THERAPEUTICS INC (NASDAQ), CORTEXYME INC (NASDAQ), CYTOKINETICS INC (NASDAQ), NANOSTRING TECHNOLOGIES INC (NASDAQ), ESPERION THERAPEUTICS INC (NASDAQ), MYRIAD GENETICS INC (NASDAQ), INTELLIA THERAPEUTICS INC (NASDAQ), AIMMUNE THERAPEUTICS INC (NASDAQ), PASSAGE BIO INC (NASDAQ), MACROGENICS INC (NASDAQ), ENANTA PHARMACEUTICALS INC (NASDAQ), TRANSLATE BIO INC (NASDAQ), ROCKET PHARMACEUTICALS INC (NASDAQ), BIOXCEL THERAPEUTICS INC (NASDAQ), KURA ONCOLOGY INC (NASDAQ), RHYTHM PHARMACEUTICALS INC (NASDAQ), STOKE THERAPEUTICS INC (NASDAQ), SORRENTO THERAPEUTICS INC (NASDAQ), IMMUNOGEN INC (NASDAQ), CUE BIOPHARMA INC (NASDAQ), OMEROS CORP (NASDAQ), BIOCRYST PHARMACEUTICALS INC (NASDAQ), AVROBIO INC (NASDAQ), ATARA BIOTHERAPEUTICS INC (NASDAQ), CELLECTIS ADS EACH REPR 1 ORD SPON (NASDAQ), CARA THERAPEUTICS INC (NASDAQ), REPLIMUNE GROUP INC (NASDAQ), NEXTCURE INC (NASDAQ), AVITA MEDICAL LTD SPON ADS EACH REP 20 ORD SHS (NASDAQ), MOLECULAR TEMPLATES INC (NASDAQ), NANTKWEST INC (NASDAQ), DYNAVAX TECHNOLOGIES CORP (NASDAQ), MORPHIC HOLDING INC (NASDAQ), RETROPHIN INC (NASDAQ), HOMOLOGY MEDICINES INC (NASDAQ), AUTOLUS THERAPEUTICS PLC SPON ADS EA REP 1 ORD SHS (NASDAQ), ZIOPHARM ONCOLOGY INC (NASDAQ), AGENUS INC (NASDAQ), STEMLINE THERAPEUTICS INC (NASDAQ), MERIDIAN BIOSCIENCE INC COM (NASDAQ), BELLUS HEALTH INC (NASDAQ), ARDELYX INC (NASDAQ), VANDA PHARMACE INC (NASDAQ), TRILLIUM THERAPEUTICS INC (NASDAQ), PREVAIL THERAPEUTICS INC (NASDAQ), CLOVIS ONCOLOGY INC (NASDAQ), SYNDAX PHARMACEUTICALS INC (NASDAQ), RADIUS HEALTH INC (NASDAQ), FLEXION THERAPEUTICS INC (NASDAQ), PACIFIC BIOSCIENCES CALIFORNIA INC (NASDAQ), DBV TECHNOLOGIES SPON ADR EACH REPR 0.5 ORD (NASDAQ), FREQUENCY THERAPEUTICS INC (NASDAQ), ATHERSYS INC (NASDAQ), PRECIGEN INC (NASDAQ), UROGEN PHARMA LTD (NASDAQ), APTOSE BIOSCIENCES INC (NASDAQ), PROTAGONIST THERAPEUTICS INC (NASDAQ), MEIRAGTX HOLDINGS PLC (NASDAQ), RUBIUS THERAPEUTICS INC (NASDAQ), ANAPTYSBIO INC (NASDAQ), VIKING THERAPEUTICS INC (NASDAQ), CORBUS PHARMACEUTICALS HOLDINGS IN (NASDAQ), INNATE PHARMA SPON ADS EACH REP 1 ORD SHS (NASDAQ), NEOLEUKIN THERAPEUTICS INC (NASDAQ), GERON CORP (NASDAQ), SCHOLAR ROCK HOLDING CORPORATION (NASDAQ), VBI VACCINES INC CDA (NASDAQ), CO DIAGNOSTICS INC (NASDAQ), SINOVAC BIOTECH LTD (NASDAQ), RAPT THERAPEUTICS INC (NASDAQ), VOYAGER THERAPEUTICS INC (NASDAQ), MERUS B V (NASDAQ), PROTHENA CORP PLC (NASDAQ), PUMA BIOTECHNOLOGY INC (NASDAQ), SYROS PHARMACEUTICALS INC (NASDAQ), HARPOON THERAPEUTICS INC (NASDAQ), UNITY BIOTECHNOLOGY INC (NASDAQ), XENON PHARMACEUTICALS INC (NASDAQ), XBIOTECH INC (NASDAQ), PRECISION BIOSCIENCES INC (NASDAQ), CALITHERA BIOSCIENCES INC (NASDAQ), PERSONALIS INC (NASDAQ), PROGENICS PHARMACEUTICALS INC (NASDAQ), PDL BIOPHARMA INC (NASDAQ), CYTOMX THERAPEUTICS INC (NASDAQ), MAGENTA THERAPEUTICS INC (NASDAQ), SERES THERAPEUTICS (NASDAQ), VERMILLION INC (NASDAQ), AVID BIOSERVICES INC (NASDAQ), SELECTA BIOSCIENCES INC (NASDAQ), KAMADA (NASDAQ), WAVE LIFE SCIENCES LTD (NASDAQ), SPECTRUM PHARMACEUTICALS INC (NASDAQ), RIGEL PHARMACEUTICALS INC (NASDAQ), BICYCLE THERAPEUTICS PLC SPON ADS EACH REP 1 ORD SHS (NASDAQ), VERASTEM INC (NASDAQ), NEPTUNE WELLNESS SOLUTIONS INC (NASDAQ), MANNKIND CORPORATION (NASDAQ), EIGER BIOPHARMACEUTICALS INC (NASDAQ), PROQR THERAPEUTICS N V (NASDAQ), CONCERT PHARMACEUTICALS INC (NASDAQ), CYMABAY THERAPEUTICS INC (NASDAQ), CASI PHARMACEUTICALS INC (NASDAQ), CHIASMA INC (NASDAQ), AFFIMED N V (NASDAQ), CELLULAR BIOMEDICINE GROUP INC (NASDAQ), FORTRESS BIOTECH INC (NASDAQ), ADMA BIOLOGICS INC (NASDAQ), LIMINAL BIOSCIENCES INC (NASDAQ), SUMMIT THERAPEUTICS PLC ADS EACH REPR 5 ORD (NASDAQ), MEDICINOVA INC (NASDAQ), BRAINSTROM CELL THERAPEUTICS (NASDAQ), XOMA CORP (NASDAQ), NEUROBO PHARMACEUTICALS INC (NASDAQ), ANAVEX LIFE SCIENCES CORPORATION (NASDAQ), TIZIANA LIFE SCIENCES PLC SPON ADS EACH REPR 10 ORD SHS (NASDAQ), INFLARX N V (NASDAQ), NUCANA PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), ADURO BIOTECH INC (NASDAQ), CHIMERIX INC (NASDAQ), AXCELLA HEALTH INC (NASDAQ), VAXART INC (NASDAQ), IVERIC BIO INC (NASDAQ), LEXICON PHARMACEUTICALS INC (NASDAQ), GENFIT SPON ADS EACH REP 1 ORD SHS (NASDAQ), ARAVIVE INC (NASDAQ), PARATEK PHARMACEUTICALS INC (NASDAQ), PLURISTEM THERAPEUTICS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), JOUNCE THERAPEUTICS INC (NASDAQ), FENNEC PHARMACEUTICALS INC (NASDAQ), STRONGBRIDGE BIOPHARMA PLC (NASDAQ), PIERIS PHARMACEUTICALS INC (NASDAQ), IMV INC (NASDAQ), FIVE PRIME THERAPEUTICS (NASDAQ), TAIWAN LIPOSOME COMPANY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ORGENESIS INC (NASDAQ), KEZAR LIFE SCIENCES INC (NASDAQ), EVOFEM BIOSCIENCES INC (NASDAQ), CELYAD ADS EACH REPR 1 ORD (NASDAQ), NEUROINSIGHTS NEUROTECH (NASDAQ), GALECTIN THERAPEUTICS INC (NASDAQ), DYADIC INTERNATIONAL INC (NASDAQ), ERYTECH PHARMA SPON ADR EACH REPR 1 ORD (NASDAQ), BIOFRONTERA AG SPON ADS EACH REP TWO ORD SHS (NASDAQ), SIERRA ONCOLOGY INC (NASDAQ), CIDARA THERAPEUTICS INC (NASDAQ), X4 PHARMACEUTICALS INC (NASDAQ), ARBUTUS BIOPHARMA CORP (NASDAQ), SOLID BIOSCIENCES INC (NASDAQ), TREVENA INC (NASDAQ), CABALETTA BIO INC (NASDAQ), ALDEYRA THERAPEUTICS (NASDAQ), CATALYST BIOSCIENCES INC (NASDAQ), ELOXX PHARMACEUTICALS INC (NASDAQ), CONTRAFECT CORP (NASDAQ), LA JOLLA PHARMACEUTICAL CO (NASDAQ), SURFACE ONCOLOGY INC (NASDAQ), T2 BIOSYSTEMS INC (NASDAQ), SAVARA INC (NASDAQ), APPLIED GENETIC TECHNOLOGIES CORP (NASDAQ), WINDTREE THERAPEUTICS INC (NASDAQ), AXOVANT GENE THERAPIES LTD (NASDAQ), AVEO PHARMACEUTICALS INC (NASDAQ), GLYCOMIMETICS INC (NASDAQ), AVALON GLOBOCARE CORP (NASDAQ), COHBAR INC (NASDAQ), CATABASIS PHARMACEUTICALS INC (NASDAQ), CHAMPIONS ONCOLOGY INC (NASDAQ), LUMOS PHARMA INC (NASDAQ), RECRO PHARMA INC (NASDAQ), NABRIVA THERAPEUTICS PLC (NASDAQ), OUTLOOK THERAPEUTICS INC (NASDAQ), HARVARD BIOSCIENCE INC (NASDAQ), LEAP THERAPEUTICS INC (NASDAQ), ORGANOVO HLDGS INC (NASDAQ), AQUABOUNTY TECHNOLOGIES INC (NASDAQ), ONCOLYTICS BIOTECH INC (NASDAQ), MONOPAR THERAPEUTICS INC (NASDAQ), OTONOMY INC (NASDAQ), SESEN BIO INC (NASDAQ), RESTORBIO INC (NASDAQ), ONCONOVA THERAPEUTICS INC (NASDAQ), SYNLOGIC INC (NASDAQ), CAPRICOR THERAPEUTICS INC (NASDAQ), ALPINE IMMUNE SCIENCES INC (NASDAQ), EDAP TMS S.A. SPON ADR EACH REPR 1 ORD SHARE (NASDAQ), STEALTH BIOTHERAPEUTICS CORP SPON ADS EACH REP 12 ORD SHS (NASDAQ), GENOCEA BIOSCIENCES INC (NASDAQ), PROTEOSTASIS THERAPEUTICS INC (NASDAQ), DIAMEDICA THERAPEUTICS INC (NASDAQ), HEAT BIOLOGICS INC (NASDAQ), ASLAN PHARMACEUTICALS LIMITED ADS EACH REP 5 ORD SHS (NASDAQ), DIFFUSION PHARMACEUTICALS INC (NASDAQ), IDERA PHARMACEUTICALS INC (NASDAQ), ANPAC BIO MEDICAL SCIENCE CO LTD SPON ADS EACH REPR 1 ORD SHS CLASS A (NASDAQ), VACCINEX INC (NASDAQ), INMUNE BIO INC (NASDAQ), VASCULAR BIOGENICS LTD (NASDAQ), EQUILLIUM INC (NASDAQ), 9 METERS BIOPHARMA INC (NASDAQ), IMMUTEP LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), MICROBOT MEDICAL INC (NASDAQ), INFINITY PHARMACEUTICALS INC (NASDAQ), SOLIGENIX INC (NASDAQ), SEELOS THERAPEUTICS INC (NASDAQ), OPIANT PHARMACEUTICALS INC (NASDAQ), MIRAGEN THERAPEUTICS INC (NASDAQ), MEREO BIOPHARMA GROUP PLC SPON ADS EACH REP 5 ORD SHS (NASDAQ), ANIXA BIOSCIENCES INC (NASDAQ), ADVAXIS INC (NASDAQ), PULMATRIX INCORPORATED (NASDAQ), BELLICUM PHARMACEUTICALS (NASDAQ), ENTASIS THERAPEUTICS HLDGS INC (NASDAQ), SUNESIS PHARMACEUTICALS INC (NASDAQ), FORWARD PHARMA AS SPON ADS EACH REP 14 ORD SHS (NASDAQ), HTG MOLECULAR DIAGNOSTICS INC (NASDAQ), SONNET BIOTHERAPEUTICS HLDGS INC (NASDAQ), ACORDA THERAPEUTICS INC (NASDAQ), ATYR PHARMA INC (NASDAQ), BIONANO GENOMICS INC (NASDAQ), EVOGENE LTD (NASDAQ), TOCAGEN INC (NASDAQ), CURIS INC (NASDAQ), KAZIA THERAPEUTICS LIMITED SPON ADR EACH REP 10 ORD SHS (NASDAQ), BIOCARDIA INC (NASDAQ), AETERNA ZENTARIS INC (NASDAQ), AZURRX BIOPHARMA INC (NASDAQ), ALIMERA SCIENCES INC (NASDAQ), AIKIDO PHARMA INC (NASDAQ), SELLAS LIFE SCIENCES GROUP INC (NASDAQ), CYCLACEL PHARMACEUTICALS INC (NASDAQ), VISTAGEN THERAPEUTICS INC (NASDAQ), ITERUM THERAPEUTICS PLC (NASDAQ), CLEVELAND BIOLABS INC (NASDAQ), BIO-PATH HOLDINGS INC (NASDAQ), APTEVO THERAPEUTICS INC (NASDAQ), GENETIC TECHNOLOGIES SPON ADS EA REP 600 ORD SHS(R/S) (NASDAQ), UNUM THERAPEUTICS INC (NASDAQ), OCUGEN INC (NASDAQ), ACHIEVE LIFE SCIENCE INC (NASDAQ), SENECA BIOPHARMA INC (NASDAQ), ARCA BIOPHARMA INC (NASDAQ), ENDRA LIFE SCIENCES INC (NASDAQ), TRACON PHARMACEUTICALS INC (NASDAQ), PHIO PHARMACEUTICALS CORP (NASDAQ), PRECIPIO INC (NASDAQ), CELLECT BIOTECHNOLOGY LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), REXAHN PHARMACEUTICALS INC (NASDAQ), ALTERITY THERAPEUTICS LIMITED SPON ADS EA REPR 60 ORD SHS (NASDAQ), CELLECTAR BIOSCIENCES INC (NASDAQ), ANCHIANO THERAPEUTICS LTD SPON ADS EACH REP 5 ORD SHS (NASDAQ), INVIVO THERAPEUTICS HOLDING CORP (NASDAQ), MIDATECH PHARMA PLC SPON ADS EACH REP 5 ORD SHS(R/S) (NASDAQ), PLUS THERAPEUTICS INC (NASDAQ), SENESTECH INC (NASDAQ), XTL BIOPHARMACEUTICALS LTD SPON ADS EACH REP 100 ORD SHS(POST SPLT) (NASDAQ), XENETIC BIOSCIENCES INC (NASDAQ), AURIS MEDICAL HOLDING LTD (NASDAQ), THERAPIX BIOSCIENCES LTD SPON ADR EACH REP 40 ORD (POST SPLIT) (NASDAQ), PLIANT THERAPEUTICS INC (NASDAQ)
Global Peer CSL ASX 133,594.837 49.795 46.118 15.4473 0.901
Global Peer AMGEN-T HKEx 588,247.000 9.574 9.804 8.0015 4.569
Global Peer AGILENT TECHNOLOGIES INC NYSE 27,941.231 26.089 40.910 5.8601 0.726
Global Peer WUXI BIO HKEx 170,620.276 148.421 148.421 11.9310 -
Global Peer SINO BIOPHARM HKEx 169,070.787 55.084 55.589 4.8798 0.593
Global Peer BEIGENE HKEx 100,571.378 - - 4.6140 -
Global Peer GENSCRIPT BIO HKEx 36,075.885 - - 12.0950 -
Global Peer EMERGENT BIOSOLUTIONS INC NYSE 4,527.141 83.067 66.478 4.2121 -
Global Peer Lonza SGX 5,937.453 6.613 6.613 0.6568 4.787
Global Peer 3SBIO HKEx 25,385.000 22.991 22.991 2.3578 -
Other Global Peers ALPHAMAB-B (HKEx), ARCUS BIOSCIENCES INC (NYSE), MESOBLAST LTD (ASX), VIVA BIOTECH (HKEx), MYOVANT SCIENCES LTD (NYSE), HAOHAI BIOTEC (HKEx), POLYNOVO LIMITED (ASX), FRONTAGE (HKEx), KINTOR PHARMA-B (HKEx), ASCENTAGE-B (HKEx), AVITA MEDICAL LTD (ASX), KADMON HLDGS INC (NYSE), SINOMAB BIO-B (HKEx), NANOVIRICIDES INC (NYSE American), ASCLETIS-B (HKEx), ESSEX BIO-TECH (HKEx), LEE'S PHARM (HKEx), CAN FITE BIOPHARMA LTD SPON ADS EA REP 30 ORD SHS(POST REV SPL (NYSE American), DPHARMA (Bursa), BBI LIFE SCI (HKEx), TELIX PHARMACEUTIC (ASX), NEXT SCIENCE LTD (ASX), PFENEX INC (NYSE American), IBIO INC (NYSE American), ENZO BIOCHEM INC (NYSE), LINEAGE CELL THERAPEUTICS INC (NYSE American), CEL-SCI CORP (NYSE American), NEUREN PHARMACEUTICALS LTD (ASX), UNI-BIO GROUP (HKEx), IMUGENE LIMITED (ASX), PALATIN TECHNOLOGIES INC (NYSE American), 22ND CENTURY GROUP INC (NYSE American), MATINAS BIOPHARMA HOLDINGS INC (NYSE American), AIM IMMUNOTECH INC (NYSE American), ARMATA PHARMACEUTICALS INC (NYSE American), INVEX THERAPEUTICS LTD NPV (ASX), IMMUTEP LTD (ASX), CYNATA THERAPEUTICS LTD (ASX), SYNTHETIC BIOLOGICS INC (NYSE American), BIOTRON (ASX), CT ENTERPRISE (HKEx), MEMPHASYS LTD (ASX), BIOSINO BIO-TEC (HKEx), GENETIC TECHNOLOGIES (ASX), HOLISTA COLLTECH LIMITED (ASX), KAZIA THERAPEUTICS LIMITED (ASX), ORAGENICS INC (NYSE American), CCP TECHNOLOGIES LTD (ASX), ANTEOTECH LIMITED (ASX), BIONOMICS LTD (ASX), Suntar Eco-City (SGX), SIENNA CANCER DIAGNOSTICS LTD (ASX), ACTINIUM PHARMACEUTICALS INC (NYSE American), ACTINOGEN MEDICAL LTD (ASX), PRESCIENT THERAPEUTICS LIMITED (ASX), INDIA GLOBALIZATION CAPITAL INC (NYSE American), REGENT PACIFIC (HKEx), REGENEUS LTD (ASX), RHINOMED LIMITED (ASX), NOVABAY PHARMACEUTICALS INC (NYSE American), ALTERITY THERAPEUTICS LIMITED (ASX), PATRYS LIMITED (ASX), NEUROSCIENTIFIC BIOPHARMA LTD (ASX), CONTANGO ASSET MANAGEMENT LIMITED (ASX), ADALTA LTD (ASX), AVECHO BIOTECHNOLOGY LTD (ASX), CRYOSITE (ASX), HAO WEN HLDGS (HKEx), AMPLIA THERAPEUTICS LTD (ASX), ANATARA LIFESCIENCES LTD (ASX), AUSTRALIAN PRIMARY HEMP LTD (ASX), LIVING CELL TECHNOLOGIES (ASX), LEAF RESOURCES LTD (ASX), NANOLLOSE LTD (ASX), FACTOR THERAPEUTICS LIMITED (ASX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.170
+5.11 %
10 Days -+0.110
+3.24 %
20 Days --0.290
-7.65 %
Medium Term Return 3 Months -+0.380
+12.18 %
6 Months --0.387
-9.96 %
1 Year 1.497-0.556
+23.20 %
Long Term Return 2 Years 1.497-2.828
-21.03 %
3 Years 1.497-7.058
-52.67 %
5 Years 2.552-50.247
-88.74 %
Annualised Return Annualised --
-35.39 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 1.490 - 5.505 Change From 1 Year Low +2.010 % Change From 1 Year Low (%) +134.90
Change From 1 Year High -2.005 % Change From 1 Year High (%) -36.42
2 Years Range 1.490 - 7.366 Change From 2 Years Low +2.010 % Change From 2 Years Low (%) +134.90
Change From 2 Years High -3.866 % Change From 2 Years High (%) -52.49
5 Years Range 1.490 - 61.833 Change From 5 Years Low +2.010 % Change From 5 Years Low (%) +134.90
Change From 5 Years High -58.333 % Change From 5 Years High (%) -94.34
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
03 Jun 2020 3.540 3.610 3.480 3.500 28,372 -
02 Jun 2020 3.580 3.580 3.460 3.520 4,760 -
01 Jun 2020 3.400 3.600 3.310 3.560 33,732 -
29 May 2020 3.310 3.395 3.280 3.390 9,617 -
28 May 2020 3.400 3.490 3.330 3.330 12,188 -
27 May 2020 3.360 3.370 3.270 3.340 17,359 -
26 May 2020 3.470 3.470 3.308 3.380 17,315 -
22 May 2020 3.340 3.470 3.340 3.460 11,173 -
21 May 2020 3.430 3.480 3.390 3.390 11,646 -
20 May 2020 3.430 3.500 3.410 3.500 16,449 -
19 May 2020 3.500 3.500 3.350 3.480 46,713 -
18 May 2020 3.620 3.620 3.420 3.500 24,634 -
15 May 2020 3.411 3.628 3.411 3.600 5,969 -
14 May 2020 3.540 3.540 3.380 3.480 13,166 -
13 May 2020 3.660 3.660 3.420 3.570 15,780 -
12 May 2020 3.700 3.760 3.529 3.600 32,754 -
11 May 2020 3.850 3.880 3.670 3.700 52,461 -
08 May 2020 3.750 3.900 3.750 3.870 15,545 -
07 May 2020 3.870 3.890 3.749 3.790 12,207 -
06 May 2020 3.790 3.880 3.755 3.880 33,128 -
05 May 2020 3.730 3.870 3.680 3.790 101,539 -
04 May 2020 3.720 3.722 3.607 3.720 10,221 -
Summary
Current 2 Weeks
(20 May 2020 to 03 Jun 2020)
3.430 3.610 3.270 3.500 162,611 -
Previous 2 Weeks
(06 May 2020 to 19 May 2020)
3.790 3.880 3.270 3.480 252,357 -
4 Weeks from
(07 Apr 2020 to 05 May 2020)
3.610 3.610 2.970 3.790 1,169,959 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.